Day: March 31, 2021

                                                                                                                                                                                                                   COMMUNIQUE DE PRESSE MISE A JOUR CONCERNANT L’ETUDE DE PHASE 3 DU MASITINIB (AB12003) DANS LE CANCER DE LA PROSTATE METASTATIQUE HORMONO-RESISTANT (mCRPC) ELIGIBLE A LA CHIMIOTHERAPIE Paris, 31 mars 2021, 18h AB Science SA (NYSE Euronext – FR0010557264 – AB) communique ce jour une mise à jour du calendrier des résultats finaux de son étude de phase 3 du masitinib (AB12003) dans le traitement du cancer de la prostate métastatique hormono-résistant (mCRPC) éligible à la chimiothérapie. Les résultats finaux de l’étude seront disponibles en avril 2021. A propos de l’étude AB12003 L’étude AB12003 est une étude internationale,...

Download Aedifica’s 2019/2020 Annual Financial Report by clicking on the link below. Annual financial reportRapport financier annuelJaarlijks financieel verslag

Í samræmi við 84. gr. laga um verðbréfaviðskipti nr. 108/2007, um breytingu á hlutafé eða atkvæðisrétti útgefanda, tilkynnist hér með að heildarfjöldi hluta í Símanum hf. er í dag, 31. mars 2021, kr. 7.540.000.000 að nafnverði og fylgir eitt atkvæði hverjum hlut í félaginu. Félagið á 30.859.967 eigin hluti. Vísað er til tilkynningar frá félaginu um lækkun hlutafjár frá 18. mars 2021. Nánari upplýsingar veitir Davíð Scheving fjárfestatengill Símans í netfangi fjarfestatengsl@siminn.is.

DANBURY, CT, March 31, 2021 (GLOBE NEWSWIRE) — Ethan Allen has continued to strengthen its retail position by relocating and redesigning multiple Design Centers during the past 12 months. The company also continues to strengthen its manufacturing in North America, where about 75% of its products are made. These moves capitalize on the brand’s ongoing commitment to combining technology with personal service and growing its strong North American manufacturing base. New and relocated Design Centers opened in past 12 months include San Mateo, California; Green Bay, Wisconsin; Oxnard, California; Towson, Maryland; Alpharetta, Georgia; and last week, in Portland, Oregon. “Ethan Allen has evolved into an all-in-one, whole-home custom design house,” stated Farooq Kathwari, Chairman and CEO of Ethan Allen Interiors Inc. “Our newest Design...

Earnings conference call to be held Wednesday, March 31, 2021 at 8:30 a.m. ET AUSTIN, TX, March 31, 2021 (GLOBE NEWSWIRE) — AYRO, Inc. (Nasdaq: AYRO) (“AYRO” or the “Company”), a designer and manufacturer of light-duty, short-haul, and last-mile delivery electric vehicles (EVs), today announced financial results for its fiscal year ended 12/31/20. Fiscal Year 2020 Financial Highlights:Revenue of $1.6 million (+80% YOY) in FY2020 vs. $0.9 million for FY2019 Net Loss Attributable to Common Stockholders of ($11.2) million in FY2020 vs. ($8.6) million in FY2019 Adjusted EBITDA loss of ($7.8) million for FY 2020 vs. ($4.4) million for FY2019 Total Cash of $36.5 million as of December 31, 2020 vs. $0.6 million as of December 31, 2019 Total debt of $0.02 million as of December 31, 2020 vs. $1.3 million as of December 31, 2019Recent...

Admiral Markets AS püstitas 2020. aastal tegutsemisaja kasumirekordi 2020. aasta oli Admiral Markets AS tegutsemisaja edukaim. Ettevõtte puhaskasum oli 20,3 miljonit eurot, mida on 340% rohkem kui aasta varem. Tehingute maht kasvas aastaga 110%. Admiral Markets AS-i kauplemise netotulu kasvas möödunud aastal 47,1 miljoni euroni. 2019. aastal oli vastav näitaja 23,2 miljonit eurot. Puhaskasumi marginaal oli 2020. aasta kokkuvõttes 43% (2019: 20%). 2020. aastal tegid Admiral Markets AS kliendid 66,9 miljonit tehingut, võrdluses aasta varasemaga, mil vastav näitaja oli 31,8 miljonit.  Admiral Markets AS juhatuse esimees Sergei Bogatenkov ütles, et möödunud aasta rekordtulemused viisid ettevõtte märgatavalt lähemale 2030. aastaks seatud eesmärgile- pakkuda finantsvabadust 10 miljonile kliendile. “Loomulikult oleme äriliste tulemuste üle väga...

Admiral Markets AS püstitas 2020. aastal tegutsemisaja kasumirekordi 2020. aasta oli Admiral Markets AS tegutsemisaja edukaim. Ettevõtte puhaskasum oli 20,3 miljonit eurot, mida on 340% rohkem kui aasta varem. Tehingute maht kasvas aastaga 110%. Admiral Markets AS-i kauplemise netotulu kasvas möödunud aastal 47,1 miljoni euroni. 2019. aastal oli vastav näitaja 23,2 miljonit eurot. Puhaskasumi marginaal oli 2020. aasta kokkuvõttes 43% (2019: 20%). 2020. aastal tegid Admiral Markets AS kliendid 66,9 miljonit tehingut, võrdluses aasta varasemaga, mil vastav näitaja oli 31,8 miljonit.  Admiral Markets AS juhatuse esimees Sergei Bogatenkov ütles, et möödunud aasta rekordtulemused viisid ettevõtte märgatavalt lähemale 2030. aastaks seatud eesmärgile- pakkuda finantsvabadust 10 miljonile kliendile. “Loomulikult oleme äriliste tulemuste üle väga...

TORONTO, March 31, 2021 (GLOBE NEWSWIRE) — African Gold Group, Inc. (TSX-V: AGG) (“AGG” or the “Company”) clarifies that further to a press release issued earlier today that announced a grant of a total of 2,800,000 stock options to certain officers, directors and consultants of the Company pursuant to the Company’s stock option plan at an exercise price of $0.115 per option, the exercise price should have read $0.15 per option. All other terms of the options that are in force for a period of five years from the date of grant remain the same. This grant of options is subject to the approval of the TSX Venture Exchange. About African Gold Group African Gold Group is a TSX Venture Exchange (TSX-V: AGG) listed exploration and development company with a focus on building Africa’s next mid-tier gold producer. The Company has a highly...

MIRAMAR, Fla., March 31, 2021 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (OTCQB: GNBT) (“Generex or the “Company”), an innovative and integrated healthcare holding company with end-to-end solutions for patient centric care including the development of its innovative “Complete Vaccine” to fight SARS-CoV-2, today announced that it will hold a shareholder conference call on Thursday May 6, 2021 at 9:00 AM ET. On this upcoming conference call, Generex President and Chief Executive Officer Joseph Moscato will provide a comprehensive update to shareholders detailing the company’s most recent corporate developments and achievements since their last call. Mr. Moscato will discuss advancements regarding its FDA IND submission where Generex has surpassed the final threshold and has completed its GMP manufacturing of its vaccine...